Assessment of a Mobile App by Adolescents and Young Adults With Cystic Fibrosis: Pilot Evaluation.
adolescence
cystic fibrosis
mHealth
mobile phone
mobile phone app
self-management
Journal
JMIR mHealth and uHealth
ISSN: 2291-5222
Titre abrégé: JMIR Mhealth Uhealth
Pays: Canada
ID NLM: 101624439
Informations de publication
Date de publication:
21 11 2019
21 11 2019
Historique:
received:
07
10
2018
accepted:
21
07
2019
revised:
25
03
2019
entrez:
22
11
2019
pubmed:
22
11
2019
medline:
17
9
2020
Statut:
epublish
Résumé
Cystic fibrosis (CF) continues to be the most common life-limiting chronic pulmonary disease in adolescents and young adults. Treatment of CF demands a high treatment time investment to slow the progression of lung function decline, the most important contributor to morbidity and mortality. Adherence is challenging in CF due to the high treatment burden and the lack of immediate health consequences in case of nonadherence. Lung function decline is particularly pronounced in the transition phase between 12 and 24 years of age. The improvement of self-management and self-responsibility and independence from parents and desire for normalcy are conflicting aspects for many adolescents with CF, which influence adherence to the time-consuming pulmonary therapy. Mobile health (mHealth) care apps could help to support self-management and independence and thereby reconcile seemingly conflicting goals to improve adherence, quality of life, and ultimately CF life expectancy. This study aimed to (1) assess user behavior and satisfaction among adolescents and young adults with CF over an observation period of three months using an mHealth app; (2) identify areas of improvement for this mHealth app; and (3) compare overall and disease-specific satisfaction, lung function, and anthropometry before and after using the mHealth app. A total of 27 adolescents and young adults with CF (age range 12-24 years, mean age 16 years, SD 3 years; 14 females, 11 males) used a free mHealth app for three months of whom 25 provided questionnaire data for analysis at the end of the study. Data collection was carried out using questionnaires on usage characteristics and life satisfaction, and standardized assessment of lung function and anthropometry. The use of the reminder function for medication declined from 70% (15/21) of the participants at week 4 to 65% (13/20) at week 8 of the observation period. At the end of the study, only 17% (4/23) of the participants wanted to continue using the app. Nevertheless, 56% (14/25) of participants saw the mobile app as a support for everyday life. Potential improvements targeting hedonistic qualities were identified to improve mHealth app adherence. Comparisons of satisfaction with different life aspects hinted at improvements or stabilization for the subitem respiration and the subitem lack of handicap by CF, suggesting that app use might stabilize certain CF-specific aspects of the weighted satisfaction with life. Lung function and anthropometry were not affected consistently. Most of the patients did not want to continue using the app after the study period. Only a few CF-specific aspects of weighted life satisfaction were possibly stabilized by the mHealth app; clinical parameters were not affected. Adaptation of the functions to adolescent-specific needs could improve the long-term use and thus positively affect the disease course.
Sections du résumé
BACKGROUND
Cystic fibrosis (CF) continues to be the most common life-limiting chronic pulmonary disease in adolescents and young adults. Treatment of CF demands a high treatment time investment to slow the progression of lung function decline, the most important contributor to morbidity and mortality. Adherence is challenging in CF due to the high treatment burden and the lack of immediate health consequences in case of nonadherence. Lung function decline is particularly pronounced in the transition phase between 12 and 24 years of age. The improvement of self-management and self-responsibility and independence from parents and desire for normalcy are conflicting aspects for many adolescents with CF, which influence adherence to the time-consuming pulmonary therapy. Mobile health (mHealth) care apps could help to support self-management and independence and thereby reconcile seemingly conflicting goals to improve adherence, quality of life, and ultimately CF life expectancy.
OBJECTIVE
This study aimed to (1) assess user behavior and satisfaction among adolescents and young adults with CF over an observation period of three months using an mHealth app; (2) identify areas of improvement for this mHealth app; and (3) compare overall and disease-specific satisfaction, lung function, and anthropometry before and after using the mHealth app.
METHODS
A total of 27 adolescents and young adults with CF (age range 12-24 years, mean age 16 years, SD 3 years; 14 females, 11 males) used a free mHealth app for three months of whom 25 provided questionnaire data for analysis at the end of the study. Data collection was carried out using questionnaires on usage characteristics and life satisfaction, and standardized assessment of lung function and anthropometry.
RESULTS
The use of the reminder function for medication declined from 70% (15/21) of the participants at week 4 to 65% (13/20) at week 8 of the observation period. At the end of the study, only 17% (4/23) of the participants wanted to continue using the app. Nevertheless, 56% (14/25) of participants saw the mobile app as a support for everyday life. Potential improvements targeting hedonistic qualities were identified to improve mHealth app adherence. Comparisons of satisfaction with different life aspects hinted at improvements or stabilization for the subitem respiration and the subitem lack of handicap by CF, suggesting that app use might stabilize certain CF-specific aspects of the weighted satisfaction with life. Lung function and anthropometry were not affected consistently.
CONCLUSIONS
Most of the patients did not want to continue using the app after the study period. Only a few CF-specific aspects of weighted life satisfaction were possibly stabilized by the mHealth app; clinical parameters were not affected. Adaptation of the functions to adolescent-specific needs could improve the long-term use and thus positively affect the disease course.
Identifiants
pubmed: 31750841
pii: v7i11e12442
doi: 10.2196/12442
pmc: PMC6895868
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e12442Informations de copyright
©Isa Rudolf, Katharina Pieper, Helga Nolte, Sibylle Junge, Christian Dopfer, Annette Sauer-Heilborn, Felix C Ringshausen, Burkhard Tümmler, Ute von Jan, Urs-Vito Albrecht, Jan Fuge, Gesine Hansen, Anna-Maria Dittrich. Originally published in JMIR mHealth and uHealth (http://mhealth.jmir.org), 21.11.2019.
Références
J Med Internet Res. 2015 Dec 23;17(12):e287
pubmed: 26701961
J Med Internet Res. 2016 May 16;18(5):e97
pubmed: 27185295
J Dev Behav Pediatr. 1991 Aug;12(4):236-42
pubmed: 1939678
BMJ Open. 2017 Mar 16;7(3):e014931
pubmed: 28302638
JMIR Mhealth Uhealth. 2018 May 08;6(5):e113
pubmed: 29739742
Lancet. 2012 Apr 28;379(9826):1630-40
pubmed: 22538178
JMIR Mhealth Uhealth. 2014 Oct 24;2(4):e44
pubmed: 25344616
Proc Am Thorac Soc. 2007 Aug 1;4(4):299-301
pubmed: 17652489
Inform Health Soc Care. 2013 Dec;38(4):354-65
pubmed: 23957685
Chest. 2003 Jan;123(1):42-8
pubmed: 12527601
Eur Respir J. 1992 Apr;5(4):452-62
pubmed: 1563504
Adolesc Health Med Ther. 2016 Oct 21;7:117-124
pubmed: 27799838
Inform Health Soc Care. 2008 Sep;33(3):158-69
pubmed: 18850399
Med Princ Pract. 2014;23(5):393-402
pubmed: 24434297
Adolesc Med. 2000 Oct;11(3):589-603
pubmed: 11060556
PLoS One. 2015 Jan 28;10(1):e0116980
pubmed: 25629939
J Cyst Fibros. 2005 Mar;4(1):59-66
pubmed: 15752683
Biomed Instrum Technol. 2012 Fall;Suppl:49-56
pubmed: 23039777
J Cyst Fibros. 2005 Mar;4(1):7-26
pubmed: 15752677